Quality of Life After Liver Resection
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients with malignant diseases are increasingly receiving more extensive hepatic resections, with im-proved preoperative and postoperative care leading to a reduced postoperative morbidity and mortality. In this setting, postoperative quality of life may become as important as overall patient survival. In this study we will be investigating the effect of the initial disease for which hepatic resection was carried out on short- and long-term quality of life.
| Condition |
|---|
|
Liver Diseases Liver Neoplasms |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Long-term Evaluation of the Quality of Life After Major Hepatic Resection for Malignant and Benign Diseases. |
- Quality of Life [ Time Frame: preoperatively, 1-,3-,6-,12 months postoperatively ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 200 |
| Study Start Date: | February 2008 |
| Estimated Study Completion Date: | January 2014 |
| Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
malignant
eg. hepatocellular carcinoma, colorectal liver metastases
|
|
benign
eg. liver cysts, traumatic liver injuries, adenoma etc
|
Detailed Description:
Background: Due to advances in operative methods and perioperative care, mortality and morbidity following major hepatic resection have decreased substantially, making long-term quality of life (QoL) an increasingly prominent issue.
Objectives: We plan on evaluating whether postoperative diagnosis is associated with long-term QoL and health in patients who require hepatic surgery for benign or malignant diseases and how QoL evolves with time.
Method: QoL will be evaluated using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 and the liver-specific QLQ-LMC21 module. All patients requiring hepatic surgery aged >18 years will be included in the study. QoL evaluation is carried out preoperatively and at set intervals postoperatively.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
All patients requiring liver resection for any benign or malignant liver diseases, including secondary tumours
Inclusion Criteria:
- Patients with planned liver resection
Exclusion Criteria
- Patients with biopsy of the liver only
- Inability of understanding the questionnaire
Contacts and Locations| Switzerland | |
| Department of visceral and transplant surgery, Bern University Hospital | |
| Bern, Switzerland, 3010 | |
| Principal Investigator: | Vanessa Banz, MD | Dep. of Visceral and transplant Surgery, University Hospital Berne, Switzerland |
More Information
Publications:
| Responsible Party: | Vanessa Banz, MD, Dep. of Visceral and Transplant surgery, Bern University Hospital, Switzerland |
| ClinicalTrials.gov Identifier: | NCT00681499 History of Changes |
| Other Study ID Numbers: | KEK 18/08 |
| Study First Received: | May 19, 2008 |
| Last Updated: | January 11, 2013 |
| Health Authority: | Switzerland: Ethikkommission |
Keywords provided by University of Bern:
|
Quality of Life Liver Neoplasms Surgical procedures, Operative |
Additional relevant MeSH terms:
|
Neoplasms Liver Diseases Liver Neoplasms |
Digestive System Diseases Digestive System Neoplasms Neoplasms by Site |
ClinicalTrials.gov processed this record on May 22, 2013